The store will not work correctly when cookies are disabled.
(2-bromophenyl)(2-hydroxy-4,6-dimethoxy-3-(morpholinomethyl)phenyl)methanone
ID: ALA1088969
PubChem CID: 46884332
Max Phase: Preclinical
Molecular Formula: C20H22BrNO5
Molecular Weight: 436.30
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: COc1cc(OC)c(C(=O)c2ccccc2Br)c(O)c1CN1CCOCC1
Standard InChI: InChI=1S/C20H22BrNO5/c1-25-16-11-17(26-2)18(19(23)13-5-3-4-6-15(13)21)20(24)14(16)12-22-7-9-27-10-8-22/h3-6,11,24H,7-10,12H2,1-2H3
Standard InChI Key: LZBAFBMRJORJPE-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 29 0 0 0 0 0 0 0 0999 V2000
2.7694 -16.3041 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7682 -17.1315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4831 -17.5444 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1995 -17.1310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.1966 -16.3005 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4813 -15.8914 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0534 -17.5434 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.3393 -17.1304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4788 -15.0664 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.1920 -14.6517 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9146 -17.5424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.9096 -15.8853 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.6256 -16.2951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9064 -15.0603 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6253 -17.1178 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3405 -17.5275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0544 -17.1122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0486 -16.2830 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3329 -15.8770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3255 -15.0520 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
3.4829 -18.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7683 -18.7817 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.0551 -18.3706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3426 -18.7794 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3382 -19.6048 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.0524 -20.0197 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7710 -19.6092 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
12 14 2 0
2 7 1 0
13 15 2 0
3 4 2 0
15 16 1 0
7 8 1 0
16 17 2 0
17 18 1 0
6 9 1 0
18 19 2 0
19 13 1 0
4 5 1 0
19 20 1 0
9 10 1 0
3 21 1 0
2 3 1 0
21 22 1 0
22 23 1 0
4 11 1 0
5 6 2 0
5 12 1 0
6 1 1 0
12 13 1 0
22 27 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 27 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 436.30 | Molecular Weight (Monoisotopic): 435.0681 | AlogP: 3.24 | #Rotatable Bonds: 6 |
Polar Surface Area: 68.23 | Molecular Species: ACID | HBA: 6 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 6.44 | CX Basic pKa: 5.23 | CX LogP: 3.69 | CX LogD: 2.91 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.70 | Np Likeness Score: -0.38 |
References
1. Bandgar BP, Patil SA, Totre JV, Korbad BL, Gacche RN, Hote BS, Jalde SS, Chavan HV.. (2010) Synthesis and biological evaluation of nitrogen-containing benzophenone analogues as TNF-alpha and IL-6 inhibitors with antioxidant activity., 20 (7): [PMID:20207143] [10.1016/j.bmcl.2010.02.001] |